# The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children

> **NCT01138215** · PHASE4 · COMPLETED · sponsor: **The HIV Netherlands Australia Thailand Research Collaboration** · enrollment: 60 (actual)

## Conditions studied

- HIV Infections
- Varicella-zoster Virus

## Interventions

- **BIOLOGICAL:** VZV vaccination

## Key facts

- **NCT ID:** NCT01138215
- **Lead sponsor:** The HIV Netherlands Australia Thailand Research Collaboration
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01138215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01138215, "The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01138215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*